Error: Could not add to watchlist. X

Tekla Healthcare Investors

+ Watchlist
XHQHX:US
NASDAQ GM
36.33
USD
0.04
0.11%
As of 20:00:00 ET on 07/31/2015.
Fund Type
Closed-End Fund
52Wk Range
27.52 - 37.63
1 Yr Return
39.69%
YTD Return
19.68%
Open
36.33
Day Range
36.33 - 36.33
Previous Close
36.29
52Wk Range
27.52 - 37.63
1 Yr Return
39.69%
YTD Return
19.68%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/30/2015)
36.33
Total Assets (b USD) (on 06/26/2015)
1.308
Inception Date
04/22/1987
Last Dividend (on 05/22/2015)
0.68
Dividend Indicated Gross Yield
7.49%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
0.95%
Expense Ratio
1.13%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 993.77 k 114.56 m 9.26
Gilead Sciences Inc 997.39 k 97.87 m 7.91
Allergan plc 252.90 k 75.27 m 6.08
Biogen Inc 163.46 k 69.02 m 5.58
Regeneron Pharmaceuticals Inc 132.64 k 59.89 m 4.84
Alexion Pharmaceuticals Inc 297.31 k 51.52 m 4.17
BioMarin Pharmaceutical Inc 406.55 k 50.66 m 4.10
Incyte Corp 508.32 k 46.59 m 3.77
Amgen Inc 244.17 k 39.03 m 3.16
Vertex Pharmaceuticals Inc 326.09 k 38.47 m 3.11
Profile
Tekla Healthcare Investors Fund is a diversified, closed-end management investment company incorporated in the USA. The Trust's objective seeks long term capital appreciation. The Trust will invest 80% of its assets in health services and medical technology companies, that have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500